BIOLOGY
纳安生物
Nanolattix Biomedical R & D Platform
Give full play to the advantages of biotechnology, innovative biological medicine, long-term and short-term combination
Study of anti-tumor drug targets and screening of specific antibodies.
Anticancer ADC drug development, both injectable and non-injectable.
Oncology diagnosis and treatment are accompanied by the development of diagnostic reagents.
An antibody screening platform has been established to screen specific antibodies against drug targets and tumor markers.
Development of new antibody-coupled anti-cancer drugs, including nanobody ADCs and dual-antibody ADCs, including injectable and non-injectable formulations
Development of companion diagnostic reagents for cancer diagnosis and treatment targeting tumor markers and drug targets
